Concentrations of cefotaxime in bronchial secretions

C Morel et al. J Antimicrob Chemother. 1980 Sep.

. 1980 Sep:6 Suppl A:123-4.

doi: 10.1093/jac/6.suppl_a.123.

No abstract available

Similar articles

[Penetration of cefotaxime into bronchial secretions].
Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y. Bergogne-Berezin E, et al. Pathol Biol (Paris). 1982 Jun;30(6 Pt 2):501-5. Pathol Biol (Paris). 1982. PMID: 6289226 French.
Penetration of cefotaxime into bronchial secretions.
Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y. Bergogne-Berezin E, et al. Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S392-5. doi: 10.1093/clinids/4.supplement_2.s392. Rev Infect Dis. 1982. PMID: 6294788
Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.
Lode H, Kemmerich B, Gruhlke G, Dzwillo G, Koeppe P, Wagner I. Lode H, et al. J Antimicrob Chemother. 1980 Sep;6 Suppl A:193-8. doi: 10.1093/jac/6.suppl_a.193. J Antimicrob Chemother. 1980. PMID: 6252156 No abstract available.
[Cefotaxime (klaforan) in modern therapy of bacterial infections].
Khess R, Budanov SV. Khess R, et al. Antibiot Khimioter. 1996 Mar;41(3):44-56. Antibiot Khimioter. 1996. PMID: 8967803 Review. Russian. No abstract available.
Respiratory tract penetration of quinolone antimicrobials: a case in study.
Ritrovato CA, Deeter RG. Ritrovato CA, et al. Pharmacotherapy. 1991;11(1):38-49. Pharmacotherapy. 1991. PMID: 2020610 Review.

Selective decontamination of the digestive tract. Theoretical and practical treatment recommendations.
Boom S, Ramsay G. Boom S, et al. Drugs. 1991 Oct;42(4):541-50. doi: 10.2165/00003495-199142040-00001. Drugs. 1991. PMID: 1723360 Review. No abstract available.